RO-0282425

RO-0282425
Clinical data
Other namesRO0282425
Routes of
administration		Unspecified
Drug classMelanocortin MC4 receptor agonist
ATC code
  • None

RO-0282425 is a melanocortin MC4 receptor agonist which was under development for the treatment of erectile dysfunction but was never marketed. Its route of administration was unspecified. The drug was under development by Roche. It reached phase 2 clinical trials by 2005 but its development was subsequently discontinued. The chemical structure of RO-0282425, and whether it is a small molecule or a peptide, do not appear to have been disclosed.

See also

References

  1. 1 2 3 4 5 6 "RO 0282425". AdisInsight. 4 March 2010. Retrieved 27 January 2026.
  2. 1 2 3 "Delving into the Latest Updates on RO-0282425 with Synapse". Synapse. 3 January 2026. Retrieved 27 January 2026.